enaira digital currency- Top Knowledge graph

Bei Ya raised the Amazon target price from $220.00 to $260.00.In November, the real effective interest rate of the Russian ruble decreased by 1.6% from the previous month.Keheng shares: signed a cooperation framework agreement with Gree supply chain, and Keheng shares announced that the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology signed a cooperation framework agreement with Gree supply chain. Gree supply chain granted Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of 650 million yuan in raw material procurement business.

As a result of providing loans with private fund property, Haisi Quanzong's private placement and responsible person were supervised to issue a warning letter. On December 13th, Qingdao Securities Regulatory Bureau issued a notice saying that after investigation, Qingdao Haisi Quanzong Private Fund Management Co., Ltd. (hereinafter referred to as "Haisi Quanzong Private Placement") provided loans with private fund property, which violated the regulations. Song Xiuhong was then the legal representative and chairman of Haisi Quanzong Private Equity, and Liu Jialiang is now the legal representative and chairman of Haisi Quanzong Private Equity. Since the establishment of Haisi Quanzong Private Equity, Wang Zhaohui has been the general manager. During his tenure, he failed to fulfill his duties and strictly abide by laws and regulations, and was responsible for the above acts. Qingdao Securities Regulatory Bureau took administrative supervision measures to issue warning letters to Haisi Quanzong Private Equity, Song Xiuhong, Liu Jialiang and Wang Chaohui.Weilai announced that the number of power exchanges had exceeded 60 million times. Weilai issued a document saying that as of 21:06:08 on December 13th, 2024, Weilai had changed power more than 60 million times! Thank you for your support and trust in Weilai.Ma Zhaoxu, Vice Minister of Foreign Affairs met with New Zealand Ambassador to China Maury, and Ma Zhaoxu, Vice Minister of Foreign Affairs met with outgoing New Zealand Ambassador to China Maury. Ma Zhaoxu said that under the strategic guidance of the leaders of the two countries, China-Singapore relations have maintained sound development, and mutual benefit and win-win have become the main tone of bilateral relations. The two sides should jointly implement the important consensus of the leaders of the two countries and promote the continued healthy and stable development of China-Singapore comprehensive strategic partnership. Mao Rui said that New Zealand is willing to strengthen dialogue and communication with China and push forward bilateral relations. (Ministry of Foreign Affairs)

Zhuhai Guanyu: It was selected as the designated supplier of low-voltage lithium batteries for its 12V cars after being notified by domestic car companies. Zhuhai Guanyu announced that the company was recently notified by a domestic car company and was selected as the designated supplier of low-voltage lithium batteries for its 12V cars. This appointment will help to enhance the company's competitiveness and sustainable development ability in this field, and lay the foundation for future market share enhancement. At present, the company has been recognized by many well-known car companies, such as SAIC, Zhiji, Jaguar Land Rover, Stellantis, GM, etc., and has obtained a number of vehicle project designation letters. However, the fixed-point notice is not the final supply agreement, and the project needs to go through many links from fixed-point to mass production, so it is uncertain whether the order can be obtained in the end.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Bei Ya raised Broadcom's target price from $195.00 to $210.00.